Skip to content

To explore the association between ultra-short heart rate variability and atrial fibrillation in chronic heart failure population

To explore the association between ultra-short heart rate variability and atrial fibrillation in chronic heart failure population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092516
Enrollment
Unknown
Registered
2024-11-18
Start date
2025-01-02
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure with reduced ejection fraction and heart failure with mildly reduced ejection fraction

Interventions

Observation group:None

Sponsors

Beijing Tsinghua Changgung Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age>=18 years. People with chronic heart failure who meet the diagnostic criteria for heart failure in the 2024 Chinese Guidelines for the Diagnosis and Treatment of Heart Failure, with mildly decreased ejection fraction and decreased ejection fraction and improved ejection fraction. The following conditions are met: 1. Medical history: coronary atherosclerotic heart disease, hypertension, high-risk factors for heart failure, use of diuretics, orthopnea/paroxysmal dyspnea at night 2. Signs: pulmonary rales, edema of both lower extremities, heart murmur, jugular venous distention, lateral or diffuse apical pulsation 3. Chest X-ray showed pulmonary congestion/edema, heart enlargement, and abnormal electrocardiogram 4. NT-proBNP>=125ng/L or BNP>=35ng/L, or strong suspicion of heart failure or NT-proBNP/BNP is not available 5. Echocardiography shows LVEF <50% NYHA Grading II-III

Exclusion criteria

Exclusion criteria: People who have a clear diagnosis of atrial fibrillation or atrial flutter in the past Patients with atrial pacing dependence Patients with acute heart failure and acute exacerbations of chronic heart failure History of severe liver and kidney disease (eGFR<30 mL/min/1.73m^2), severe lung disease, malignant tumor and psychiatric disease; Pregnant women, women of childbearing potential who plan to become pregnant during the study or are unable to achieve effective contraception during the study Life expectancy < 12 months due to the disease; Not signed informed consent.

Design outcomes

Primary

MeasureTime frame
Atrial fibrillation;Atrial flutter;Subclinical atrial fibrillation;

Secondary

MeasureTime frame
All-cause mortality;Major cardiovascular events;Kansas City Cardiomyopathy Questionnaire (KCCQ-12) scores;

Countries

China

Contacts

Public ContactRong He

Beijing Tsinghua Changgung Hospital

dr_herong@sina.com+86 10 5611 9519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026